Perinatal Psychotropic Safety
On this page
Direct answer
Stopping an effective psychotropic at the first missed period trades a small fetal risk for a very high relapse risk — with lithium discontinued in pregnancy, roughly half of women with bipolar disorder relapse, and an untreated psychotic or manic mother harms herself and the fetus as surely as any drug. The hierarchy to memorise: valproate is the drug to avoid in women who may conceive (major malformation risk in the region of 6-10%, neural tube defects foremost, now governed by a pregnancy prevention programme), lithium carries a small Ebstein anomaly risk of about 0.1% — roughly tenfold baseline yet still low in absolute terms — and lamotrigine is among the safer mood stabilisers. Sertraline and paroxetine transfer least into breast milk; fluoxetine and clozapine are the ones to avoid while breastfeeding.
What you must remember
- Valproate: highest teratogenic risk (about 6-10% major malformations; neural tube, cardiac, cognitive effects); contraindicated in women of childbearing potential unless a pregnancy prevention programme with reliable contraception is in place.
- Lithium: Ebstein anomaly (tricuspid valve) risk roughly 0.05-0.1% — about a tenfold increase over baseline; if continued, give once-daily at night, monitor levels closely (clearance rises in pregnancy), and hydrate around delivery.
- Lamotrigine: relatively preferred in pregnancy; clearance rises markedly so doses need increase, and a modest oral-cleft signal is reported — folate supplementation is routine.
- Antidepressants: no agent is clearly major-teratogenic; paroxetine carries the best-known cardiac septal defect signal; untreated depression predicts poor obstetric and neonatal outcomes too.
- Breastfeeding picks: sertraline and paroxetine have the lowest relative infant doses and are preferred; fluoxetine (long half-life, active metabolite) and clozapine (sedation, agranulocytosis risk to the infant) are avoided.
- Postpartum psychosis (1-2 per 1000 deliveries) is a psychiatric emergency with infanticidal and suicidal risk — often the strongest argument for continuing prophylaxis, and ECT is a legitimate, safe perinatal treatment.
- Indian nuance: postpartum psychosis in rural India is sometimes first attributed to possession or "navjata" beliefs, delaying psychiatric presentation; cultural formulation helps reach treatment faster.
Weighing risks at the bedside
Walk through a 27-year-old with bipolar I on lithium, planning pregnancy. Pre-conception is where the real counselling happens: options include continuing lithium with enhanced monitoring (levels each trimester, night-time dosing, hydration plan for labour), switching to a lower-risk agent such as lamotrigine or quetiapine before conception, or a planned taper if her episode history is mild — each traded openly against her past relapse pattern, because the strongest predictor of perinatal relapse is recent illness. A targeted anomaly scan at 18-20 weeks covers the cardiac question lithium raises.
The same patient on sertraline for depression who becomes pregnant does not stop the drug mid-trimester on a relative's advice; the relapse risk of abrupt cessation exceeds the small and inconsistent fetal signals. After delivery comes a triple decision: breastfeeding, drug choice, and the high-risk puerperium — the two weeks postpartum carry the maximum relapse danger in bipolar disorder, and sleep protection for the mother (a named night carer for the baby) is a genuinely evidence-flavoured intervention. In India, where the joint family provides hands, that carer is often already present; harnessing the family structure is perinatal psychiatry in an Indian key.
How the exam frames it
Two anchors dominate the MCQ bank: valproate as the most teratogenic psychotropic (with the pregnancy-prevention caveat) and lithium-Ebstein as the classic pair — the number 0.1% appears in options. Breastfeeding questions invert the pregnancy list: paroxetine, avoided by many prescribers in pregnancy because of the cardiac signal, becomes one of the SAFEST in lactation because of negligible milk transfer — that inversion is the trap. Postpartum psychosis as emergency, its 1-2 per 1000 incidence, and the place of ECT (safe in pregnancy, definitive in puerperal psychosis) complete the set.
Frequently asked questions
Which mood stabiliser carries the highest teratogenic risk?
Valproate, with major malformation rates around 6-10% and neural tube defects prominent — avoid in women of childbearing potential unless a strict pregnancy prevention programme is followed.
What is the Ebstein anomaly risk with lithium?
Roughly 0.05-0.1%, about ten times the background rate but low in absolute terms — many pregnancies on monitored lithium result in healthy infants.
Which antidepressants are preferred during breastfeeding?
Sertraline and paroxetine, because relative infant doses are minimal; fluoxetine and clozapine are avoided in lactation.
How common is postpartum psychosis and why is it an emergency?
It affects about 1-2 per 1000 deliveries, typically within the first two weeks, and carries significant risks of infanticide and suicide requiring urgent hospitalisation.
Is ECT permissible during pregnancy?
Yes — it is a safe and often fastest option for severe perinatal depression, mania or psychosis when drugs are ineffective or dangerous, with standard obstetric monitoring.